Question 1

What is Li Jing?

Accepted Answer

Li Jing is a Person.

Question 2

How often does Li Jing appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Li Jing first tracked by Ergen?

Accepted Answer

First tracked on Jul 01, 2026.

Question 4

When was Li Jing last mentioned in news?

Accepted Answer

Last active on Jul 02, 2026.

Question 5

What is Li Jing's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Li Jing in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Li Jing?

Accepted Answer

Junshi Biosciences licenses roconkibart to Fosun Wanbang (Jul 01, 2026, 8 articles).

Question 8

How did the "Junshi Biosciences licenses roconkibart to Fosun Wanbang" event impact Li Jing?

Accepted Answer

Li Jing, Co-President of Fosun Pharmaceutical Group and Chairman of Fosun International — Fosun Wanbang Pharma Group, emphasized the strategic partnership's role in addressing unmet clinical needs in autoimmune diseases and enriching Fosun Pharmaceutical Group's immunology and inflammation portfolio.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.